Significant Updates on the Following Companies and New Coverage
April 20 2017 - 9:00AM
InvestorsHub NewsWire
After strengthening its balance sheet at the end of last year
DryShips, Inc. (NASDAQ:
DRYS), a diversified shipping company, planned to
rebuild its depleted fleet and they have done exactly that. Since
the beginning of this year the company has acquired 14 vessels,
paying a total of $ 663 million and bringing the strength of its
fleet back to 20 vessels. U.S. Stem Cell, Inc. (OTCQB:
USRM) has received reactivation status of the MARVEL
phase II/III trial with the Food and Drug Administration (FDA). The
trial had previously been placed on "Inactive Status" as patients
were not actively being enrolled. USRM is in the process of
launching new clinics and programs in the Middle East and China
that will feature its technologies, therapies, and products.
American Leisure Holdings, Inc. (OTCBB:
AMLH) recently announced that the company will be
working with The Engine for upcoming series developments, including
a winning line-up of eSports content for sale and distribution to
both traditional network television and digital platforms. In March
the company finalized a merger with GG
Media Network, a rising eSports media production
company. Ems Find, Inc. (OTCBB:
EMSF) will be changing the name of the Company
to Paradigm Group, Inc. The company intends to file with FINRA
for approval of the name change for trading purposes and a new
trading symbol. Ems Find, Inc., a wholly owned subsidiary of the
Paradigm Group, Inc. is an applications and software development
company focused on the healthcare transportation sector.
Our comprehensive report and the ticker we are initiating coverage
on today can be viewed here with no obligation- http://tradersnewssource.com/traders-news-report/
DISCLOSURE
Traders News Source LLC (TNS) produces
regular sponsored and non-sponsored reports, articles, stock market
blogs, and popular investment newsletters covering small and
micro-cap equity markets. TNS has two distinct and independent
departments. One department produces non-sponsored analyst
certified content generally in the form of press releases, articles
and reports covering equities listed on NYSE, NASDAQ and OTC
exchanges. The other produces sponsored content (in most cases not
reviewed by a registered analyst), which typically consists of
compensated investment newsletters, articles and reports covering
listed stocks and micro-caps. Such sponsored content is outside the
scope of procedures detailed below.
TNS has not been compensated; directly or
indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES
The non-sponsored content contained
herein has been prepared by a writer (the "Author") and is fact
checked and reviewed by a third-party research service company (the
"Reviewer") represented by a chartered financial analyst, for
further information on analyst credentials, please email
editor@tradersnewssource.com. TNS LLC editor Mark Roberts, (the
"Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as
necessary, based on publicly available information which is
believed to be reliable. Content is researched, written, and
reviewed on a reasonable-effort basis. The Reviewer has not
performed any independent investigations or forensic audits to
validate the information herein. The Reviewer has only
independently reviewed the information provided by the Author per
the procedures outlined by TNS. TNS is not entitled to veto or
interfere in the application of such procedures by the third-party
research service company to the articles, documents, or reports.
Unless otherwise noted, any content outside of this document has no
association with the Author or the Reviewer in any way.
NO WARRANTY
TNS, the Author, and the Reviewer are not
responsible for any error which may be occasioned at the time of
printing of this document or any error, mistake, or shortcoming. No
liability is accepted whatsoever for any direct, indirect, or
consequential loss arising from the use of this document. TNS, the
Author, and the Reviewer expressly disclaim any fiduciary
responsibility or liability for any consequences, financial or
otherwise arising from any reliance placed on the information in
this document. Additionally, TNS, the Author, and the Reviewer do
not (1) guarantee the accuracy, timeliness, completeness, or
correct sequencing of the information, or (2) warrant any results
from use of the information. The included information is subject to
change without notice.
NOT AN OFFERING
This document is not intended as an
offering, recommendation, or a solicitation of an offer to buy or
sell the securities mentioned or discussed, and is to be used for
informational purposes only. Please read all associated disclosures
and disclaimers in full before investing. Neither TNS nor any party
affiliated with us is a registered investment adviser or
broker-dealer with any agency or in any jurisdiction whatsoever. To
download our report(s), read our disclosures, or for more
information, visit http://www.tradersnewssource.com.
For any questions, inquiries, or comments
reach out to us directly. If you're a company we are covering and
wish to no longer be featured on our coverage list, contact us via
email at: editor@tradersnewssource.com
CFA® and Chartered Financial Analyst® are
registered trademarks owned by CFA Institute.
CONTACT: editor@tradersnewssource.com
SOURCE: Traders News Source
US Stem Cell (CE) (USOTC:USRM)
Historical Stock Chart
From Oct 2024 to Nov 2024
US Stem Cell (CE) (USOTC:USRM)
Historical Stock Chart
From Nov 2023 to Nov 2024